Knowledge Management System of Institute of Zoology, CAS
Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations | |
Source Publication | SCIENCE ADVANCES
![]() |
2018 | |
Volume | 4Issue:11Pages:文献号 eaau0731:1-11 |
Jaesung P.Choi; Rui Wang; Xi Yang; Xian Wang; Lu Wang; Ka Ka Ting; Matthew Foley; Victoria Cogger; Zhuo Yang; Liu F(刘峰); Han ZM(韩之明); Renjing Liu; Jonathan Baell; Xiangjian Zheng | |
Document Type | 期刊论文 |
Identifier | http://ir.ioz.ac.cn/handle/000000/13477 |
Collection | 干细胞与生殖生物学国家重点实验室 |
Recommended Citation GB/T 7714 | Jaesung P.Choi,Rui Wang,Xi Yang,et al. Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations[J]. SCIENCE ADVANCES,2018,4(11):文献号 eaau0731:1-11. |
APA | Jaesung P.Choi.,Rui Wang.,Xi Yang.,Xian Wang.,Lu Wang.,...&Xiangjian Zheng.(2018).Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations.SCIENCE ADVANCES,4(11),文献号 eaau0731:1-11. |
MLA | Jaesung P.Choi,et al."Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations".SCIENCE ADVANCES 4.11(2018):文献号 eaau0731:1-11. |
Files in This Item: | Download All | |||||
File Name/Size | DocType | Version | Access | License | ||
Ponatinib (AP24534) (1766KB) | 期刊论文 | 出版稿 | 开放获取 | CC BY-NC-SA | View Download |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment